Harmony Biosciences Holdings Inc (HRMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 136,201 | 85,336 | 45,560 | 145,493 | 96,018 |
| Depreciation Amortization | 17,153 | 11,360 | 5,683 | 22,551 | 16,905 |
| Income taxes - deferred | -14,677 | -10,796 | -4,311 | -29,298 | -22,586 |
| Accounts receivable | -17,618 | -9,948 | -22,936 | -8,893 | -7,362 |
| Accounts payable and accrued liabilities | 12,597 | 14,557 | 3,715 | -5,384 | -8,596 |
| Other Working Capital | 17,780 | -12,362 | -25,862 | -7,321 | -23,137 |
| Other Operating Activity | 70,612 | 35,167 | 32,138 | 102,673 | 93,017 |
| Operating Cash Flow | $222,048 | $113,314 | $33,987 | $219,821 | $144,259 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -203 | -132 | -128 | -1,153 | -640 |
| Net Acquisitions | N/A | N/A | N/A | -33,069 | -33,069 |
| Purchase Of Investment | -67,313 | -43,032 | -19,132 | -105,289 | -69,604 |
| Sale Of Investment | 60,500 | 40,937 | 21,622 | 98,527 | 68,516 |
| Other Investing Activity | -15,000 | -15,000 | 0 | -26,500 | -25,500 |
| Investing Cash Flow | $-22,016 | $-17,227 | $2,362 | $-67,484 | $-60,297 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -11,250 | -7,500 | -3,750 | -15,000 | -11,250 |
| Common Stock Issued | 7,557 | 6,803 | 4,706 | 6,501 | 3,264 |
| Other Financing Activity | -2,341 | -2,341 | -1,308 | -2,497 | -269 |
| Financing Cash Flow | $-6,034 | $-3,038 | $-352 | $-10,996 | $-8,255 |
| Beginning Cash Position | 453,271 | 453,271 | 453,271 | 311,930 | 311,930 |
| End Cash Position | 647,269 | 546,320 | 489,268 | 453,271 | 387,637 |
| Net Cash Flow | $193,998 | $93,049 | $35,997 | $141,341 | $75,707 |
| Free Cash Flow | |||||
| Operating Cash Flow | 222,048 | 113,314 | 33,987 | 219,821 | 144,259 |
| Capital Expenditure | -203 | -132 | -128 | -1,153 | -640 |
| Free Cash Flow | 221,845 | 113,182 | 33,859 | 218,668 | 143,619 |